Evaluation and Management of Antenatal HydronephrosisEvaluation and Management of Antenatal Hydronephrosis.
10.3339/chikd.2015.19.1.8
- Author:
Young Kwon HONG
1
;
Jun Ho LEE
Author Information
1. Department of Urology, CHA Bundang Medical Center, CHA University, Seongnam, South Korea. ykhongmd@gmail.com
- Publication Type:Review
- Keywords:
Hydronephrosis;
Prenatal diagnosis;
Child;
Diagnostic imaging
- MeSH:
Anti-Bacterial Agents;
Child;
Consensus;
Diagnosis;
Diagnostic Imaging;
Female;
Gestational Age;
Humans;
Hydronephrosis*;
Infant;
Male;
Oligohydramnios;
Pregnancy;
Prenatal Diagnosis;
Radioisotope Renography;
Ultrasonography;
Ureter;
Urinary Bladder Neck Obstruction;
Urinary Tract;
Urinary Tract Infections
- From:Childhood Kidney Diseases
2015;19(1):8-13
- CountryRepublic of Korea
- Language:English
-
Abstract:
Antenatal hydronephrosis (ANH) is one of the most common abnormal findings detected on prenatal ultrasound (US), and it has been reported in 1-5% of all pregnancies. The likelihood of significant postnatal pathologic abnormality in the urinary tract correlates with the degree of anterior-posterior diameter (APD) according to the gestational age. Detection of urologic anomalies prenatally permits fetal interventions that avoid complications in rare cases of bladder outlet obstruction with oligohydramnios even though their final benefits still remain controversial. There is no clear consensus on the extent and mode of postnatal imaging after a diagnosis of ANH. US is the mainstay of the postnatal evaluation and helps guide further testing with voiding cystourethrography (VCUG) and diuretic renography. Although most algorithms continue to recommend generous VCUG for identification of lower urinary tract anomalies, VCUG may be safely reserved for high grade ANH cases or any grade of ANH with dilated distal ureter without increasing the risk of urinary tract infection (UTI). There are conflicting studies about efficacy of postnatal prophylactic antibiotics. It still seems reasonable to consider use of a prophylactic antibiotic to prevent infant UTIs in high-risk populations, such as females and uncircumcised males with high grades of hydronephrosis, hydroureteronephrosis, or vesicouretral reflux.
